Trending NewsTrending NewsNASDAQ:TLRY Tilray Brands (TLRY) Stock Price, News & Analysis $0.99 +0.07 (+8.04%) As of 03:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Tilray Brands Stock (NASDAQ:TLRY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tilray Brands alerts:Sign Up Key Stats Today's Range$0.96▼$1.2050-Day Range$0.36▼$0.9252-Week Range$0.35▼$1.98Volume260.96 million shsAverage Volume38.33 million shsMarket Capitalization$1.09 billionP/E RatioN/ADividend YieldN/APrice Target$1.92Consensus RatingHold Company Overview Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. Read More Tilray Brands Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreTLRY MarketRank™: Tilray Brands scored higher than 62% of companies evaluated by MarketBeat, and ranked 760th out of 1,853 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingTilray Brands has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageTilray Brands has only been the subject of 1 research reports in the past 90 days.Read more about Tilray Brands' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tilray Brands are expected to grow in the coming year, from ($0.20) to ($0.10) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tilray Brands is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tilray Brands is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTilray Brands has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Tilray Brands' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted16.49% of the outstanding shares of Tilray Brands have been sold short.Short Interest Ratio / Days to CoverTilray Brands has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Tilray Brands has recently decreased by 12.10%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTilray Brands does not currently pay a dividend.Dividend GrowthTilray Brands does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.49% of the outstanding shares of Tilray Brands have been sold short.Short Interest Ratio / Days to CoverTilray Brands has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Tilray Brands has recently decreased by 12.10%, indicating that investor sentiment is improving significantly. News and Social Media3.7 / 5News Sentiment0.60 News SentimentTilray Brands has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for Tilray Brands this week, compared to 13 articles on an average week.Search Interest51 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 59% compared to the previous 30 days.MarketBeat Follows72 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 31% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Tilray Brands insiders have bought more of their company's stock than they have sold. Specifically, they have bought $120,750.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.60% of the stock of Tilray Brands is held by insiders.Percentage Held by InstitutionsOnly 9.35% of the stock of Tilray Brands is held by institutions.Read more about Tilray Brands' insider trading history. Receive TLRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tilray Brands and its competitors with MarketBeat's FREE daily newsletter. Email Address TLRY Stock News HeadlinesInsider Buying: Tilray Brands, Inc. (NASDAQ:TLRY) CFO Buys 33,500 Shares of StockJuly 31, 2025 | insidertrades.comMarketBeat Week in Review – 07/14 - 07/18 (TLRY)The NASDAQ and S&P 500 hit all-time highs on better-than-expected economic data; the market is confirming expectations for a strong second half...July 19, 2025 | marketbeat.com#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opportunity is taking shape—one tied to what could be the largest IPO in history: Elon Musk’s Starlink. With the IPO rumored to launch as soon as this year, James has uncovered a backdoor method to potentially profit before it goes public—starting with as little as $50.August 12 at 2:00 AM | Paradigm Press (Ad)Tilray Shares Blazing: What's Behind the 55% Rally This Month?Tilray's recent 55% rally may draw investor attention, but do the potential benefits outweigh the continued risks of this cannabis leader?July 14, 2025 | marketbeat.comTilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane’s and Happy Flower BrandsAugust 12 at 7:07 AM | financialpost.comFTilray Brands: Is TLRY Stock The Next Big Thing?August 12 at 7:01 AM | forbes.comTilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane's and Happy Flower BrandsAugust 12 at 7:00 AM | globenewswire.comTraders Buy High Volume of Call Options on Tilray Brands (NASDAQ:TLRY)August 12 at 2:13 AM | americanbankingnews.comSee More Headlines TLRY Stock Analysis - Frequently Asked Questions How have TLRY shares performed this year? Tilray Brands' stock was trading at $1.33 on January 1st, 2025. Since then, TLRY stock has decreased by 21.4% and is now trading at $1.0450. How were Tilray Brands' earnings last quarter? Tilray Brands, Inc. (NASDAQ:TLRY) posted its quarterly earnings data on Monday, July, 28th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.05. The firm had revenue of $224.54 million for the quarter, compared to analysts' expectations of $250.41 million. Tilray Brands had a negative trailing twelve-month return on equity of 6.83% and a negative net margin of 265.69%. Read the conference call transcript. When did Tilray Brands IPO? Tilray Brands (TLRY) raised $135 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers. Who are Tilray Brands' major shareholders? Tilray Brands' top institutional shareholders include Swiss National Bank (0.18%), Quinn Opportunity Partners LLC (0.19%), Simplex Trading LLC and JPMorgan Chase & Co. (0.04%). Insiders that own company stock include Brendan Kennedy, Irwin D Simon, Carl A Merton, Denise M Faltischek and Mitchell Gendel. View institutional ownership trends. How do I buy shares of Tilray Brands? Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tilray Brands own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), Humana (HUM), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings7/28/2025Today8/12/2025Next Earnings (Estimated)10/09/2025Fiscal Year End5/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TLRY Previous SymbolNASDAQ:TLRY CIK1731348 Webwww.tilray.com Phone206-432-9325FaxN/AEmployees2,842Year FoundedN/APrice Target and Rating Average Price Target for Tilray Brands$1.92 High Price Target$3.00 Low Price Target$1.00 Potential Upside/Downside+81.7%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($2.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.19 billion Net Margins-265.69% Pretax Margin-280.33% Return on Equity-6.83% Return on Assets-5.45% Debt Debt-to-Equity Ratio0.20 Current Ratio2.46 Quick Ratio1.49 Sales & Book Value Annual Sales$821.31 million Price / Sales1.41 Cash Flow$0.23 per share Price / Cash Flow4.49 Book Value$1.40 per share Price / Book0.75Miscellaneous Outstanding Shares1,100,530,000Free Float1,093,927,000Market Cap$1.16 billion OptionableOptionable Beta1.85 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:TLRY) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredTop Picks for Trump’s Pro-Crypto America27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tilray Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tilray Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.